Our data demonstrated that bispecific FLT3scFv/NKG2D-CAR T cells effectively had binding capacity and cytotoxicity against FLT3mut+ AML cells and significantly prolonged the survival of the mice with AML established by MOLM-13 cell implantation. The gene discussed is KLRK1; the disease is acute myeloid leukemia.